
X
Ipsen craters as pricey rare disease drug is put on hold again
https://pharmaphorum.com/news/ipsen-craters-as-pricey-rare-disease-drug-is-put-on-hold-again/
What manufacturers should consider, after successfully overcoming any HTA hurdles, to achieve market access.